Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-06-07

Clinical Trial Update: Mesenchymal Stem Cells Transplantation for Liver Cirrhosis Due to HCV Hepatitis [Phase 1, Phase 2]

View source ↗

Summary

This entry reports an ongoing Phase 1/Phase 2 clinical trial evaluating mesenchymal stem cell transplantation for liver cirrhosis caused by hepatitis C, with th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesenchymal stem cell transplantation (mesenchymal stem cells)

Snippet

Sponsor: Saglik Bilimleri Universitesi Gulhane Tip Fakultesi | Conditions: Liver Cirrhosis | Phase 1, Phase 2 | Status: UNKNOWN